Nicole Ross
Adult Health · Jenkintown, PANPI 1790057677
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (45.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Exelixis Inc. accounts for 89.7% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $5,508, more than ten times the $18 reported in 2021. Among adult health clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 61 payments — averaging $165.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exelixis Inc.$9K
- Revance Therapeutics, Inc.$635
- Astellas Pharma US Inc$139
- GSK$61
- Takeda Pharmaceuticals U.S.A., Inc.$51
- Gilead$38
- plus $115 from 5 others
What the payments were for
- Speaking & faculty fees$4,55045%
- Travel & lodging$3,22432%
- Food & beverage$2,31623%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exelixis Inc. | 37 | $9,050 |
| Revance Therapeutics, Inc. | 10 | $635 |
| Astellas Pharma US Inc | 2 | $139 |
| GSK | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Gilead | 1 | $38 |
| Edwards Lifesciences | 2 | $35 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Merck | 1 | $19 |
| Pharmacosmos Therapeutics Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,089 in reported general payments places this provider in the 95th percentile of 899 adult health providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 12 | $17,925 |
| EliquisApixaban | 11 | $6,331 |
| Potassium Chloride | 24 | $698 |
| Gabapentin | 40 | $556 |
| Prochlorperazine Maleate | 26 | $440 |
| Ondansetron Hcl | 31 | $319 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 29 | $314 |
| Oxycodone Hcl | 30 | $268 |
| Pantoprazole Sodium | 16 | $264 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 15 | $123 |
| Lorazepam | 27 | $89 |
| Levothyroxine Sodium | 13 | $67 |
| Tramadol Hcl | 16 | $52 |
| Methylprednisolone | 11 | $48 |
| Furosemide | 11 | $9 |
Paid to pharmacies, not to this prescriber.
Other adult health in Jenkintown
- Beth SandyPhiladelphia$924K
- Jennifer MondilloSchwenksville$396K
- Diane NewmanPhiladelphia$343K
- Elizabeth FaustDouglassville$342K
- Abigail SmithPhiladelphia$302K
- Jean CainAllentown$214K
- Jennifer KeeleyWexford$97K
- Debra EvansFarrell$85K
- Bethann MallonBlue Bell$65K
- Catherine HoldsworthPhiladelphia$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.